SCHEMBL2025883

SCHEMBL2025883

COC(=O)NC1Cc2c(n(Cc3cccc(F)n3)c3ccc(C#N)cc23)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCARB1 Q8WTV0 3/20 0.36
HRH1 P35367 1/20 0.35
HTR6 P50406 1/20 0.35
PTGDR2 Q9Y5Y4 3/20 0.34
DRD2 P14416 1/20 0.34
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
GUCY1A1 Q02108 1/20 0.32
GUCY1B1 Q02153 1/20 0.32
KCNH2 Q12809 1/20 0.32
HTR3A P46098 1/20 0.32
PARG Q86W56 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
USP2 O75604 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
PRKAA2 P54646 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12579040 1.00 SCARB1 (0.36) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL1880004 0.94 PTGDR2 (0.41) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL1880007 0.94 PTGDR2 (0.41) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL2024659 0.93 SCARB1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL12579036 0.93 SCARB1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL16493666 0.92 HRH1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL2029678 0.92 HRH1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL16493792 0.92 HRH1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL12579034 0.92 HRH1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2
SCHEMBL12579037 0.91 SCARB1 (0.34) SCARB1HRH1HTR6PTGDR2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094658-B1 TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS LILLY CO ELI (US) 2011-12-21 EP disclosed
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, NR5A1, MUSK SCARB1 1045/4885HRH1 1313/4885HTR6 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.